LATEST NEWS & EVENTS


Post Date: Today

Look for the latest FDA safety alerts: Recalls, Market Withdrawals, and Safety Alerts

Look for the newest FDA approvals considered as "Innovation in Development of Drugs and Biological Products"


Post Date: August 12, 2018

Press Release
Sunascen Therapeutics LLC Announces a New Line of OTC Pain Relievers Along with a Simplified Pain Rating Scale.
MYGRIN® - "Helping you turn the face of pain into a grin"
Read More


Post Date: January 15, 2018

Looking for the most up to date information on Naus-Ease®?

The official Naus-Ease® website: www.nausease.com

U.S. National Library of Medicine websites:
Naus-Ease® Film Strips
Naus-Ease® Tablets


FROM MOLECULE TO MARKET AND SUPPORT
Our professionals redefine challenges into opportunities, and provide the right
assistance to fuel growth.

Pharmaceuticals & Life Sciences

Product Development, Management, and Consulting Services

Providing investors, pharmaceutical, biotechnology, and medical device companies with industry specific solutions suited for businesses of all sizes. Sunascen Therapeutics LLC is a global pharmaceutical and life science product management and advisory consulting firm. We provide services and solutions throughout the entire value chain, as well as partnership opportunities in product licensing for our global clients who wish to seek marketing approval for their products by the U.S. Food and Drug Administration (FDA).

Recent innovations and tremendous advances in research have led to immeasurable changes in the industry. These changes also stem from mergers and acquisitions, increasing regulatory scrutiny, patent and brand exclusivity expirations, patient’s therapeutic selectivity empowerment, competitive products, and cost containment pressures from government and private health insurance agencies, as well as the general public. It has also resulted in numerous spin-offs and startup companies. Therefore, evolving business optimization and continuous change management is a key factor in an organizations success, particularly in the pharmaceutical and life sciences industry. Sunascen Therapeutics experts have assisted businesses in addressing growth strategies and transformation challenges across the entire value chain. We work with investors, research organizations, global pharmaceutical, biotechnology, and medical device companies to strategically turn challenges into viable opportunities for growth.

Sunascen Therapeutics provides advisory, and management solutions designed to assist companies of all sizes in multiple functions. From developing long term growth strategies at the corporate level, expense reduction and operational excellence, to departmental restructuring and transformations. Our services allow our clients to strengthen their core functional foundations due to increasing demands with growing market shares or from rapid globalization and expansion. With capabilities, and extensive industry expertise, our management services extend to in-licensing analysis, target acquisition analysis, as well as preparation, integration, and advisory services for mergers, acquisitions, and leveraged buyouts.

In addition to our advisory and management consulting services, we develop corporate partnerships with existing, and emerging companies to commercialize their products allowing ideas to hit the market with a shattering impact which lasts throughout the products marketing exclusivity period, while maintaining regulatory and civic responsibilities. We encourage our clients to leverage our services in core functional areas to their advantage. This allows our clients to focus on their strengths, which is developing quality products based on extensive scientific research, and product engineering while allowing them to outsource all or any part of the business they choose. Sunascen Therapeutics provides a full life cycle management service from molecule to market, and support throughout the products exclusivity dates; and beyond if requested by our clients.
To learn more about our advisory and management consulting services, or product portfolio services, please refer to the services section of this website.